Published in J Gen Virol on March 01, 1990
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell (1984) 6.78
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (1985) 6.01
A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature (1982) 5.95
Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus. Proc Natl Acad Sci U S A (1983) 4.82
Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro. Proc Natl Acad Sci U S A (1971) 4.49
Independent segregation of loci for activation of biologically distinguishable RNA C-type viruses in mouse cells. Proc Natl Acad Sci U S A (1973) 4.39
Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature (1984) 4.30
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J (1989) 4.12
gag Gene of mammalian type-C RNA tumour viruses. Nature (1976) 4.11
New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J Mol Biol (1989) 4.09
The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res (1983) 4.06
Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A (1984) 3.98
The complete nucleotide sequence of a common cold virus: human rhinovirus 14. Nucleic Acids Res (1984) 3.85
Location and primary structure of a major antigenic site for poliovirus neutralization. Nature (1983) 3.64
Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol (1986) 3.50
Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J Virol (2000) 3.21
Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor. Proc Natl Acad Sci U S A (1983) 3.21
An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature (1989) 3.01
The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of the Picornaviridae. J Gen Virol (1987) 3.01
Endogenous type-C RNA viruses of mammalian cells. Biochim Biophys Acta (1976) 2.95
Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein. Proc Natl Acad Sci U S A (1977) 2.93
Cells nonproductively transformed by Abelson murine leukemia virus express a high molecular weight polyprotein containing structural and nonstructural components. Proc Natl Acad Sci U S A (1978) 2.90
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol (1989) 2.89
Amino- and carboxyl-terminal amino acid sequences of proteins coded by gag gene of murine leukemia virus. Proc Natl Acad Sci U S A (1978) 2.87
Radiommunoassays for the 70,000-molecular-weight glycoproteins of endogenous mouse type C viruses: viral antigen expression in normal mouse tissues and sera. J Virol (1976) 2.82
Isolation of temperature-sensitive mutants of murine leukemia virus. Virology (1972) 2.78
Isolation of a nucleocapsid polypeptide of herpes simplex virus types 1 and 2 possessing immunologically type-specific and cross-reactive determinants. J Virol (1979) 2.78
The nonstructural components of polyproteins encoded by replication-defective mammalian transforming retroviruses are phosphorylated and have associated protein kinase activity. Virology (1980) 2.77
Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. J Virol (2001) 2.59
Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3. Nature (1983) 2.51
Homology exists among the transforming sequences of avian and feline sarcoma viruses. Proc Natl Acad Sci U S A (1980) 2.50
Monoclonal antibodies which block cellular receptors of poliovirus. Virus Res (1984) 2.40
Antigen chimaeras of poliovirus as potential new vaccines. Nature (1988) 2.38
Genetic factors influencing C-type RNA virus induction. J Exp Med (1972) 2.36
Tick-borne encephalitis virus - a review of an emerging zoonosis. J Gen Virol (2009) 2.32
Phylogeny of the Simbu serogroup of the genus Bunyavirus. J Gen Virol (2001) 2.30
Widespread natural occurrence of high titers of neutralizing antibodies to a specific class of endogenous mouse type-C virus. Proc Natl Acad Sci U S A (1974) 2.27
Feline leukemia virus: biochemical and immunological characterization of gag gene-coded structural proteins. J Virol (1977) 2.26
Segregation of loci for C-type virus induction in strains of mice with high and low incidence of leukemia. Science (1973) 2.17
The Friend virus genome: evidence for the stable association of MuLV sequences and sequences involved in erythroleukemic transformation. Cell (1977) 2.12
Characterization of temperature-sensitive mutants of murine leukemia virus. Virology (1973) 2.05
Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U. Virology (1990) 2.03
Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol (2000) 2.00
Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J Gen Virol (1986) 1.99
A genetic locus for inducibility of C-type in BALB-c cells: the effect of a nonlinked regulatory gene on detection of virus after chemical activation. Proc Natl Acad Sci U S A (1972) 1.97
Chromosomal localization of human cellular homologues of two viral oncogenes. Nature (1982) 1.96
Tobacco use and quit attempts among methadone maintenance clients. Am J Public Health (2001) 1.88
Analysis of type specific antigenic determinants of two structural polypeptides of mouse RNA C-Type viruses. Virology (1974) 1.87
Thermolabile reverse transcriptase of a mammalian leukemia virus mutant temperature sensitive in its replication and sarcoma virus helper functions. J Virol (1975) 1.87
Characterization of strains of type 3 poliovirus by oligonucleotide mapping. J Gen Virol (1982) 1.84
Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J Virol (1997) 1.84
Defective interfering viruses and infections of animals. Curr Top Microbiol Immunol (1986) 1.83
Characterisation of L cells expressing the human poliovirus receptor for the specific detection of polioviruses in vitro. J Virol Methods (1993) 1.82
Modulation of humoral response to a 12-amino-acid site on the poliovirus virion. J Virol (1986) 1.80
Human transforming growth factors induce tyrosine phosphorylation of EGF receptors. Nature (1981) 1.78
Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector. J Gen Virol (1989) 1.77
Evidence of persistent measles virus infection in Crohn's disease. J Med Virol (1993) 1.76
Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3. Lancet (1982) 1.76
Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus. J Gen Virol (1987) 1.76
Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J (1994) 1.76
Antigenic properties of murine sarcoma virus-transformed BALB-3T3 nonproducer cells. J Exp Med (1972) 1.75
Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J Gen Virol (1985) 1.72
Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines. J Infect Dis (1991) 1.72
Genetic variation in the 3' non-coding region of dengue viruses. Virology (2001) 1.71
Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Res (1984) 1.71
The complete nucleotide sequence of coxsackievirus A21. J Gen Virol (1989) 1.70
Nucleotide sequences and phylogeny of the nucleocapsid gene of Oropouche virus. J Gen Virol (2000) 1.70
Immunological characterization of a low molecular weight polypeptide of murine leukemia virus. Virology (1973) 1.70
Murine sarcoma and leukemia viruses: genetic differences determined by RNA-DNA hybridization. Virology (1971) 1.69
Intracistronic mapping of the murine type C viral gag gene by use of conditional lethal replication mutants. Virology (1977) 1.68
The putative helicase of the coronavirus mouse hepatitis virus is processed from the replicase gene polyprotein and localizes in complexes that are active in viral RNA synthesis. J Virol (1999) 1.67
The 1st International Standard for anti-measles serum. Biologicals (1991) 1.67
The nucleotide sequence of human rhinovirus 1B: molecular relationships within the rhinovirus genus. J Gen Virol (1988) 1.67
Role for poliovirus protease 2A in cap independent translation. EMBO J (1994) 1.66
Transformation induced by Abelson murine leukemia virus involves production of a polypeptide growth factor. Science (1982) 1.66
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J Virol (2000) 1.64
Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology (1993) 1.64
Isolation of temperature-sensitive mutants of murine sarcoma virus. J Virol (1972) 1.64
The complete nucleotide sequence of enterovirus type 70: relationships with other members of the picornaviridae. J Gen Virol (1990) 1.64
Intertypic genomic rearrangements of poliovirus strains in vaccinees. Virology (1988) 1.59
Amino-terminal sequence of bovine leukemia virus major internal protein: homology with mammalian type C virus p30 structural proteins. Proc Natl Acad Sci U S A (1979) 1.57
Segregation of genetic information for a B-tropic leukemia virus with the structural locus for BALB:virus-1. Proc Natl Acad Sci U S A (1977) 1.57
Structural polypeptides of mammalian type C RNA viruses. Isolation and immunologic characterization of a low molecular weight polypeptide, p10. J Biol Chem (1976) 1.57
New mammalian transforming retrovirus: demonstration of a polyprotein gene product. J Virol (1983) 1.55
Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J Gen Virol (1986) 1.55
Genetic variation in yellow fever virus: duplication in the 3' noncoding region of strains from Africa. Virology (1996) 1.53
Demonstration of two immunologically distinct xenotropic type C RNA viruses of mouse cells. Virology (1974) 1.52
Effect of growth rate on plasmid maintenance by Escherichia coli HB101(pAT153). J Gen Microbiol (1990) 1.52
Biochemical and immunological properties of gag genecoded structural proteins of endogenous tyep C RNA tumor viruses of diverse mammalian species. J Biol Chem (1977) 1.52
Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies. J Gen Virol (1985) 1.50
Comparative biochemical studies of type 3 poliovirus. J Virol (1980) 1.49
Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa. J Virol (2001) 1.47
Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine. J Virol (1989) 1.46
The 5' noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity. Virology (1991) 1.45
Evolutionary relationships between gag gene-coded proteins of murine and primate endogenous type C RNA viruses. Cell (1977) 1.45
Expression of endogenous RNA C-type virus group-specific antigens in mammalian cells. J Virol (1973) 1.45
Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine. J Gen Virol (1995) 1.44